Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal


Classification: B

Drug products: Activelle, Activelle®, Angemin®, Climara, Climen, Climodien, Cliovelle, Delestrogen, Dermestril, Divigel®, Divina® Plus, Duova, Estalis, Estalis®, Estraderm MX, Estradiol Implant, Estradiol Valerate, Estradot, Estradot 25, Estradot®, Estramon, Estrogel, Eviana, Evopad, Evopad 25, Evorel, Evorel 100, Evorel 25, Evorel 25 Patch, Evorel 50, Evorel®, Femanest®, Femanor®, Femasekvens®, Indivina, Indivina®, Kliogest®, Lafamme, Lenzetto, Meno-Implant, Neofollin, Noresmea, Novofem®, Oestring®, Progynon®, Qlaira, Sequidot®, Systen 50, Trisekvens, Trisekvens®, Trivina®, Vagidonna, Vagifem, Vagifem®, Vagirux, Zoely

ATC code: G03AA14, G03AB08, G03CA03, G03FA01, G03FA12, G03FA15, G03FA17, G03FB05, G03FB06, G03HB01

Substances: estradiol, estradiol 3-acetate, estradiol hemihydrate, estradiol valerate


Except during medical assisted gender transition, the substance is only used by women and thus analyses on sex or gender differences have not been considered relevant.

Additional information

Estradiol is a natural steroidal estrogen primarily used alone or in combination in hormone replacement therapy or to prevent osteoporosis in postmenopausal women with a high risk of future fractures [1-2]. It is also used during medical assisted gender transition [3].

Updated: 2017-10-05

Date of litterature search: 2017-03-21


  1. Fass.se [cited 2016-12-20]. länk
  2. Physicians' Desk Reference. http://www.pdr.net. [cited 2016-12-20]. länk
  3. Deutsch MB, Bhakri V, Kubicek K. Effects of cross-sex hormone treatment on transgender women and men. Obstet Gynecol. 2015;125:605-10. PubMed
  4. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2016 [cited 2017-06-20.] länk

Authors: Mia von Euler, Linnéa Karlsson Lind

Reviewed by: Mia von Euler

Approved by: Karin Schenck-Gustafsson